153 related articles for article (PubMed ID: 6313195)
1. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.
Jones RN; Pfaller MA; Allen SD; Gerlach EH; Fuchs PC; Aldridge KE
Diagn Microbiol Infect Dis; 1991; 14(4):361-4. PubMed ID: 1889187
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of gentamicin sensitive and resistant gram negative bacilli to ceftazidime.
Bremner DA
Pathology; 1987 Jul; 19(3):274-6. PubMed ID: 3124067
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli.
Marone P; Navarra A; Monzillo V; Traverso A
Drugs Exp Clin Res; 1990; 16(12):629-33. PubMed ID: 2130005
[TBL] [Abstract][Full Text] [Related]
5. Ceftazidime and cefotaxime--the clinician's choice.
Puthucheary SD; Goldsworthy PJ
Clin Ther; 1989; 11(2):186-204. PubMed ID: 2660995
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility of some bacteria isolated from clinical samples to third-generation cephalosporins].
Willke A; Tural D
Mikrobiyol Bul; 1987 Oct; 21(4):279-83. PubMed ID: 3332704
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of several beta-lactam antibiotics against anaerobes determined by two methods.
Zabransky RJ; Birk RJ
Clin Ther; 1987; 10(1):107-25. PubMed ID: 3450391
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of BMY-28142, a new cephalosporin.
Norden CW; Neiderriter K
Chemotherapy; 1987; 33(1):15-7. PubMed ID: 3103990
[TBL] [Abstract][Full Text] [Related]
9. Third generation cephalosporins.
Donowitz GR
Infect Dis Clin North Am; 1989 Sep; 3(3):595-612. PubMed ID: 2671141
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Shibl AM; Ishag AH; Durgham SM
Chemotherapy; 1989; 35 Suppl 1():72-6. PubMed ID: 2659292
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity of newer antibiotics against gram-negative bacilli.
Knapp CC; Washington JA
Cleve Clin J Med; 1989; 56(2):161-6. PubMed ID: 2731335
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.
Sutter VL; Kirby B; Finegold SM
Rev Infect Dis; 1979; 1(1):218-23. PubMed ID: 318226
[TBL] [Abstract][Full Text] [Related]
13. New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteria.
Jones RN; Erwin ME; Bale M
Diagn Microbiol Infect Dis; 1992 Jan; 15(1):73-80. PubMed ID: 1580897
[TBL] [Abstract][Full Text] [Related]
14. Biological activity of BO-1236, a new antipseudomonal cephalosporin.
Nakagawa S; Sanada M; Matsuda K; Hazumi N; Tanaka N
Antimicrob Agents Chemother; 1987 Jul; 31(7):1100-5. PubMed ID: 3116919
[TBL] [Abstract][Full Text] [Related]
15. [Bacteriology of abdominal pus in 43 cases of acute appendicitis and appendiceal abscess at the Ivrea-Castellamonte Hospital, isolation of aerobic and anaerobic bacteria and drug sensitivity].
Guasco C; Ronchetto F; Milani P; Stacchini E; Pistono PG
G Batteriol Virol Immunol; 1991; 84(1-12):77-86. PubMed ID: 1844922
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates.
Edmiston CE; Krepel CJ; Clausz JC; Condon RE
Diagn Microbiol Infect Dis; 1988 Feb; 9(2):105-13. PubMed ID: 3164263
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of the new oxacephem antibiotic, flomoxef (6315-S).
Ruckdeschel G; Eder W
Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):687-91. PubMed ID: 3143586
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of cefoxitin against recent clinical bacterial isolates.
MacCulloch D; Cornere BM
N Z Med J; 1979 Feb; 89(629):83-5. PubMed ID: 286213
[TBL] [Abstract][Full Text] [Related]
19. In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates.
Washington JA; Jones RN; Allen SD; Gerlach EH; Koontz FP; Murray PR; Pfaller MA; Erwin ME
Antimicrob Agents Chemother; 1991 Jul; 35(7):1508-11. PubMed ID: 1929319
[TBL] [Abstract][Full Text] [Related]
20. Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.
Ernst EC; Berger S; Barza M; Jacobus NV; Tally FP
Antimicrob Agents Chemother; 1976 May; 9(5):852-5. PubMed ID: 949182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
